PEDIATRICS Vol. 63 No. 5 May 1979, pp. 694-699
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Holm, V. A.
Right arrow Articles by Knox, W. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holm, V. A.
Right arrow Articles by Knox, W. E.

Physical Growth in Phenylketonuria: I. A Retrospective Study

Vanja A. Holm M.D.1 and W. Eugene Knox M.D.1

1 Child Development and Mental Retardation Center, University of Washington, Seattle, and Harvard Medical School and New England Deaconess Hospital, Boston

A retrospective cross-sectional survey of phenylketonuria (PKU) was conducted in 1967. Questionnaires on 693 patients, clinically thought to have PKU, were reanalyzed to obtain information on growth in height and head circumference in patients with untreated and previously treated PKU. To provide a comparison to the growth findings of the Collaborative PKU Study, a definition of PKU was adopted to correspond to the one used in that study. Stature in 232 outpatients with untreated PKU was normal but, in 31 institutionalized individuals, the mean height was —1.4 standard deviations below the mean of a normal population. Head circumference in patients with untreated PKU was normal at birth, but showed an increasingly negative deviance with age and was —1.4 SD in untreated adults. Height measurements of 135 children with PKU in whom treatment was started before 121 days of age (age chosen to coincide with criteria for the Collaborative Study) had a significant reduction in height growth, —.8 SD. Head circumference measurements of 115 children treated for PKU were —.7 SD of normal. The depression in head circumference was less in treated subjects with PKU than in untreated ones of the same age. These findings are corroborated by a review of the literature, which contains no convincing report of normal growth during treatment of PKU.

Submitted on June 12, 1978
Accepted on September 25, 1978




This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
G. Courtney-Martin, R. Bross, M. Raffi, J. T. R. Clarke, R. O. Ball, and P. B. Pencharz
Phenylalanine requirement in children with classical PKU determined by indicator amino acid oxidation
Am J Physiol Endocrinol Metab, December 1, 2002; 283(6): E1249 - E1256.
[Abstract] [Full Text] [PDF]